Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FluMist vs. Flucelvax Immunogenicity in Children and Young Adults
NCT03982069Phase 4Completed
- Start
- Sep 2019
- Primary completion
- Dec 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of live attenuated influenza vaccine, Fluzone Trivalent in influenza. Started Sep 2019; status: completed.
02
Drugs
live attenuated influenza vaccineFluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03982069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03982069.